Concepedia

Miki Ando

MA

13

Publications

411

Citations

13

H-Index

1993

Active since

Affiliations

Juntendo University(Current)

Stanford University

The University of Tokyo

Kurume University

University of Tsukuba

Miki Ando is an author at Juntendo University specializing in medicine, immunology, and autoimmunity.

ORCID

Top concepts

Publications per year

1993–2023

13

Publications

13

Selective apoptosis of natural killer‐cell tumours by <b><scp>l</scp></b>‐asparaginase

Miki Ando, Koichi Sugimoto, Toshiyuki Kitoh et al. · British Journal of Haematology · 2005 · 161 citations · Full text

Dual-antigen targeted iPSC-derived chimeric antigen receptor-T cell therapy for refractory lymphoma

Sakiko Harada, Miki Ando, Jun Ando et al. · Molecular Therapy · 2021 · 44 citations · Full text

, , +14

Sustainable Tumor-Suppressive Effect of iPSC-Derived Rejuvenated T Cells Targeting Cervical Cancers

Tadahiro Honda, Miki Ando, Jun Ando et al. · Molecular Therapy · 2020 · 29 citations · Full text

Hsp90-inhibitor geldanamycin abrogates G2 arrest in p53-negative leukemia cell lines through the depletion of Chk1

Koichi Sugimoto, Makoto Sasaki, Yasushi Isobe et al. · Oncogene · 2007 · 25 citations

, , +8

Long-term eradication of extranodal natural killer/T-cell lymphoma, nasal type, by induced pluripotent stem cell-derived Epstein-Barr virus-specific rejuvenated T cells <i>in vivo</i>

Miki Ando, Jun Ando, Satoshi Yamazaki et al. · Haematologica · 2019 · 23 citations · Full text

Rows per page

1–5 of 13